Tennessee § 63-10-501 - Part definitions.

§ 63-10-501. Part definitions.

As used in this part: “Anti-rejection drug” means a prescription drug that suppresses the immune system to prevent or reverse rejection of a transplanted organ; “Board” means the board of pharmacy; “Cancer drug” means a prescription drug that is used to treat any of the following: Cancer or the side effects of cancer; or The side effects of any prescription drug that is used to treat cancer or the side effects of cancer; “Controlled substance” means the same as defined in § 39-17-402; “Department” means the department of health; “Donor” means a person, a pharmacy, or medical facility as well as any drug manufacturer or wholesaler licensed by the board of pharmacy, who donates prescription drugs to a repository program approved pursuant to this part; “Eligible individual” means an indigent person or an uninsured person who meets all other criteria established by board rule; “Indigent” means a person with an income that is below two hundred percent (200%) of the federal poverty level as defined by the most recently revised poverty income guidelines published by the United States department of health and human services; “Medical facility” means any of the following: A physician's office; A hospital; A health clinic; A nonprofit health clinic, which includes a federally qualified health center as defined in 42 U.S.C. § 1396d(l)(2)(B); a rural health clinic, as defined in 42 U.S.C. § 1396d(l)(1); and a nonprofit health clinic that provides medical care to patients who are indigent, uninsured, or underinsured; A free clinic as defined in § 63-6-703; A charitable organization as defined in § 48-101-501; or A nursing home as defined in § 68-11-201; “Pharmacy” means a pharmacy as defined in § 63-10-204; “Prescription drug” means the same as defined in § 63-10-204, except the drug is only tablet or capsule form, and includes cancer drugs and anti-rejection drugs, but does not include controlled substances and drugs covered by the risk evaluation and mitigation strategy program of the federal food and drug administration; and “Supplies” means the supplies necessary to administer the prescription drugs donated. Acts 2017, ch. 392, § 1. Compiler's Notes. Former part 5, §§ 63-10-501 — 63-10-508 , concerning the Nina Norman Prescription Drug Donation Act of 2006 is repealed by Acts 2017, ch. 392, § 1, effective January 1, 2018. Effective Dates. Acts 2017, ch. 392, § 3. January 1, 2018; provided, that for purposes of promulgating rules, the act took effect on May 18, 2017. Cross-References. Tennessee Affordable Drug Act of 2005, § 53-10-201 et seq. Tennessee Pharmacy Practice Act of 1996, title 63, ch. 10, parts 2-5.